查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1619408

2024 年α发射体世界市场报告

Alpha Emitter Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

α发射体市场规模预计在未来几年将大幅成长。 2028年，这一数字将以23.5%的复合年增长率成长至30.3亿美元。预测期内的成长可归因于医疗保健成本增加、心臟疾病患者数量增加、联合治疗增加、标靶阿尔法疗法普及率增加以及研发活动活性化。这段时期预计的主要趋势包括成像技术的进步、产品创新、策略联盟、放射性药物开发的进步以及新的α发射同位素的创造。

癌症发生率的上升预计将推动未来α发射体市场的成长。癌症是一种以形成肿瘤或侵入附近组织的异常细胞不受控制的生长和扩散为特征的疾病。导致癌症传播的因素包括人口老化、环境暴露、生活方式的改变和检测方法的改进。阿尔法发射装置用于癌症治疗，精确地瞄准并摧毁癌细胞，同时最大限度地减少对周围健康组织的伤害。例如，2023年8月，澳洲政府卫生机构澳洲健康与福利实验室宣布，到2021年，美国诊断出罹患癌症（不包括皮肤基底细胞癌和鳞状细胞癌）的人数将增加。将从2030年的151,000人增加到2030年的185,000人。因此，癌症盛行率的增加推动了α发射体市场的成长。

α发射核素市场的主要企业正在专注于投资创新解决方案，例如使用迴旋加速器生产的α发射核素，以获得竞争优势。这些放射性核素是放射性同位素，在崩坏时释放α粒子，是透过在迴旋加速器中将带电粒子加速到高能量而产生的。例如，2023年4月，美国迴旋加速器技术公司Ionetix在其位于密西根州兰辛的新α同位素生产设施中生产了第一种α发射核素砹211（At-211）。该设施是美国第一座利用迴旋加速器技术专门生产α发射核素的设施。这项生产是透过试运行30 MeV 迴旋加速器实现的，该迴旋加速器旨在加速 α 粒子以产生高产量的 At-211 和锕-225 (Ac-225)。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球α发射体市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球α发射体市场表现：规模与成长，2018-2023 年
  • 全球α发射体市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球α发射体市场：依放射性核种类型、实际与预测，2018-2023、2023-2028、2033
  • 镭
  • 锟
  • 带领
  • 铋
  • 其他类型的放射性核种
  • 全球α发射体市场：按来源、实际和预测划分，2018-2023、2023-2028、2033
  • 自然资源
  • 人工产生的来源
  • 其他的
  • 全球α发射体市场：按应用、实际和预测划分，2018-2023、2023-2028、2033
  • 胰臟癌
  • 卵巢癌
  • 摄护腺癌
  • 淋巴瘤
  • 恶性黑色素瘤
  • 骨转移
  • 其他的
  • 全球α发射体市场：按最终用户、实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 医学研究所
  • 其他的

第 7 章 区域/国家分析

  • 全球α发射体市场：按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球α发射体市场：按国家、性能和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • α发射体市场：竞争格局
  • α发射体市场：公司简介
    • Cardinal Health Inc.
    • Bayer AG
    • Lantheus Holdings Inc.
    • Curium Pharma
    • Eckert & Ziegler BEBIG GmbH

第三十一章 其他重大及创新企业

  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes LLC
  • ITM Isotope Technologies Munich SE
  • Blue Earth Diagnostics Ltd.
  • International Isotopes Inc.
  • IBA Radiopharma Solutions
  • Orano Med LLC
  • ARTbio AS
  • Actinium Pharmaceuticals Inc.
  • Clarity Pharmaceuticals Ltd.
  • RadioMedix Inc.
  • Nordic Nanovector ASA
  • Convergent Therapeutics
  • TAE Life Sciences
  • ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r20439

An alpha emitter is a type of radioactive substance that releases alpha particles during radioactive decay. It includes elements, such as uranium, radium, and plutonium, that undergo alpha decay as part of their natural radioactive processes. Alpha emitters play a significant role in medical treatments, especially cancer therapy, and in various technological applications such as smoke detectors and space exploration.

The main types of radionuclide of alpha emitters are radium, actinium, lead, bismuth, and others. Radium is a radioactive element used in medical treatments and diagnostic procedures. The source is natural sources, artificially produced sources, and others, and applications are pancreatic cancer, ovarian cancer, prostate cancer, lymphoma, melanoma, bone metastasis, and others. It is used by various end-users such as hospitals, medical research institutions, and others.

The alpha emitter market research report is one of a series of new reports from The Business Research Company that provides alpha emitter market statistics, including alpha emitter industry global market size, regional shares, competitors with a alpha emitter market share, detailed alpha emitter market segments, market trends and opportunities, and any further data you may need to thrive in the alpha emitter industry. This alpha emitter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alpha emitter market size has grown exponentially in recent years. It will grow from $1.06 billion in 2023 to $1.30 billion in 2024 at a compound annual growth rate (CAGR) of 23.2%. The growth during the historic period can be attributed to the rising incidence of cancer, increasing research investments, government support and funding, a growing aging population, and the expansion of radiotherapy centers.

The alpha emitter market size is expected to see exponential growth in the next few years. It will grow to $3.03 billion in 2028 at a compound annual growth rate (CAGR) of 23.5%. The growth during the forecast period can be attributed to rising medical expenditures, an increasing number of patients with cardiac conditions, a growing use of combination therapies, the rising prevalence of targeted alpha therapy, and heightened research and development activities. Key trends expected in this period include advancements in imaging technologies, innovations in products, strategic collaborations, progress in radiopharmaceutical development, and the creation of new alpha-emitting isotopes.

The rising prevalence of cancer is anticipated to drive the growth of the alpha emitter market in the future. Cancer is a disease marked by the uncontrolled proliferation and spread of abnormal cells, which can form tumors and invade nearby tissues. Contributing factors to cancer prevalence include aging populations, environmental exposures, lifestyle changes, and improved detection methods. Alpha emitters are utilized in cancer treatment to target and destroy tumor cells with high precision, while minimizing harm to surrounding healthy tissues. For example, in August 2023, the Australian Institute of Health and Welfare, an Australian government health administration, projected that the number of Americans diagnosed with cancer (excluding basal cell carcinomas and squamous cell carcinomas of the skin) will rise from 151,000 in 2021 to 185,000 by 2030. Consequently, the increasing prevalence of cancer is fueling the growth of the alpha emitter market.

Major companies in the alpha-emitter market are focusing on investing in innovative solutions, such as alpha-emitting radionuclides produced using cyclotrons, to gain a competitive edge. These radionuclides are radioactive isotopes that emit alpha particles during decay and are created by accelerating charged particles to high energies in a cyclotron. For example, in April 2023, Ionetix, a US-based cyclotron and technology company, produced its first alpha-emitting radionuclide, Astatine-211 (At-211), at its newly established Alpha Isotope Manufacturing facility in Lansing, Michigan. This facility is notable as the first in the U.S. dedicated exclusively to producing alpha-emitting radionuclides using cyclotron technology. The production was made possible by commissioning a 30 MeV cyclotron, designed to accelerate alpha particles for the high-yield production of At-211 and Actinium-225 (Ac-225).

In February 2024, Bristol-Myers Squibb Co. (BMS), a US-based biopharmaceutical company, acquired RayzeBio, Inc. for $4.1 billion. This acquisition allows Bristol-Myers Squibb to enhance its oncology portfolio by integrating innovative radiopharmaceutical therapies, particularly targeted alpha-emitter treatments. RayzeBio, Inc. is a US-based provider specializing in alpha emitters.

Major companies operating in the alpha emitter market are Cardinal Health Inc., Bayer AG, Lantheus Holdings Inc., Curium Pharma, Eckert & Ziegler BEBIG GmbH, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes LLC, ITM Isotope Technologies Munich SE, Blue Earth Diagnostics Ltd., International Isotopes Inc., IBA Radiopharma Solutions, Orano Med LLC, ARTbio AS, Actinium Pharmaceuticals Inc., Clarity Pharmaceuticals Ltd., RadioMedix Inc., Nordic Nanovector ASA, Convergent Therapeutics, TAE Life Sciences, ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH, Fusion Pharmaceuticals Inc.

North America was the largest region in the alpha emitter market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha emitter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the alpha emitter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alpha emitter market consists of sales of Plutonium-238 (Pu-238), Thorium-227 (Th-227), Polonium-210 (Po-210), and Americium-241 (Am-241). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alpha Emitter Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alpha emitter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for alpha emitter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alpha emitter market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type Of Radionuclide: Radium; Actinium; Lead; Bismuth; Other Types Of Radionuclides
  • 2) By Source: Natural Sources; Artificially Produced Sources; Other Sources
  • 3) By Application: Pancreatic Cancer; Ovarian Cancer; Prostate Cancer; Lymphoma; Melanoma; Bone Metastasis; Other Applications
  • 4) By End-User: Hospitals; Medical Research Institutions; Other End-Users
  • Companies Mentioned: Cardinal Health Inc.; Bayer AG; Lantheus Holdings Inc.; Curium Pharma; Eckert & Ziegler BEBIG GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Alpha Emitter Market Characteristics

3. Alpha Emitter Market Trends And Strategies

4. Alpha Emitter Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Alpha Emitter Market Size and Growth

  • 5.1. Global Alpha Emitter Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Alpha Emitter Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Alpha Emitter Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Alpha Emitter Market Segmentation

  • 6.1. Global Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Radium
  • Actinium
  • Lead
  • Bismuth
  • Other Types Of Radionuclides
  • 6.2. Global Alpha Emitter Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Natural Sources
  • Artificially Produced Sources
  • Other Sources
  • 6.3. Global Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pancreatic Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Lymphoma
  • Melanoma
  • Bone Metastasis
  • Other Applications
  • 6.4. Global Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Medical Research Institutions
  • Other End-Users

7. Alpha Emitter Market Regional And Country Analysis

  • 7.1. Global Alpha Emitter Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Alpha Emitter Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Alpha Emitter Market

  • 8.1. Asia-Pacific Alpha Emitter Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Alpha Emitter Market

  • 9.1. China Alpha Emitter Market Overview
  • 9.2. China Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Alpha Emitter Market

  • 10.1. India Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Alpha Emitter Market

  • 11.1. Japan Alpha Emitter Market Overview
  • 11.2. Japan Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Alpha Emitter Market

  • 12.1. Australia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Alpha Emitter Market

  • 13.1. Indonesia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Alpha Emitter Market

  • 14.1. South Korea Alpha Emitter Market Overview
  • 14.2. South Korea Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Alpha Emitter Market

  • 15.1. Western Europe Alpha Emitter Market Overview
  • 15.2. Western Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Alpha Emitter Market

  • 16.1. UK Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Alpha Emitter Market

  • 17.1. Germany Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Alpha Emitter Market

  • 18.1. France Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Alpha Emitter Market

  • 19.1. Italy Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Alpha Emitter Market

  • 20.1. Spain Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Alpha Emitter Market

  • 21.1. Eastern Europe Alpha Emitter Market Overview
  • 21.2. Eastern Europe Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Alpha Emitter Market

  • 22.1. Russia Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Alpha Emitter Market

  • 23.1. North America Alpha Emitter Market Overview
  • 23.2. North America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Alpha Emitter Market

  • 24.1. USA Alpha Emitter Market Overview
  • 24.2. USA Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Alpha Emitter Market

  • 25.1. Canada Alpha Emitter Market Overview
  • 25.2. Canada Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Alpha Emitter Market

  • 26.1. South America Alpha Emitter Market Overview
  • 26.2. South America Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Alpha Emitter Market

  • 27.1. Brazil Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Alpha Emitter Market

  • 28.1. Middle East Alpha Emitter Market Overview
  • 28.2. Middle East Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Alpha Emitter Market

  • 29.1. Africa Alpha Emitter Market Overview
  • 29.2. Africa Alpha Emitter Market, Segmentation By Type Of Radionuclide, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Alpha Emitter Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Alpha Emitter Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Alpha Emitter Market Competitive Landscape And Company Profiles

  • 30.1. Alpha Emitter Market Competitive Landscape
  • 30.2. Alpha Emitter Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Lantheus Holdings Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Curium Pharma
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eckert & Ziegler BEBIG GmbH
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Alpha Emitter Market Other Major And Innovative Companies

  • 31.1. Telix Pharmaceuticals Limited
  • 31.2. NorthStar Medical Radioisotopes LLC
  • 31.3. ITM Isotope Technologies Munich SE
  • 31.4. Blue Earth Diagnostics Ltd.
  • 31.5. International Isotopes Inc.
  • 31.6. IBA Radiopharma Solutions
  • 31.7. Orano Med LLC
  • 31.8. ARTbio AS
  • 31.9. Actinium Pharmaceuticals Inc.
  • 31.10. Clarity Pharmaceuticals Ltd.
  • 31.11. RadioMedix Inc.
  • 31.12. Nordic Nanovector ASA
  • 31.13. Convergent Therapeutics
  • 31.14. TAE Life Sciences
  • 31.15. ABX-CRO advanced pharmaceutical services Forschungsgesellschaft mbH

32. Global Alpha Emitter Market Competitive Benchmarking

33. Global Alpha Emitter Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Alpha Emitter Market

35. Alpha Emitter Market Future Outlook and Potential Analysis

  • 35.1 Alpha Emitter Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Alpha Emitter Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Alpha Emitter Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer